Medical Device News Magazine

FloSpine Revolutionizes Treatment for Spinal Stenosis with FDA Clearance of KeyLift™ System

KeyLift is the fifth FDA-approved product developed by FloSpine, all invented at the Research Park at Florida Atlantic University®

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Together with FloSpine, the Research Park at Florida Atlantic University® is pleased to announce that FloSpine has achieved 510(k) clearance for its KeyLift™ Expandable Interlaminar Stabilization System from the FDA, and has expanded out of the Global Ventures entrepreneur support center into a new, larger office to support its growth.

The newly approved device addresses spinal stenosis, a common and debilitating condition that affects more than 100 million people worldwide, resulting in approximately 600,000 surgeries annually in the United States alone. It occurs when the spinal canal narrows, causing pressure on the nerves and leading to severe back and leg pain, weakness, and numbness. Traditional treatment options for spinal stenosis have often involved invasive surgical procedures with lengthy recovery times. The KeyLift system introduces a less invasive alternative, enabling spine and interventional pain physicians to administer this revolutionary treatment in an outpatient surgery center.

The KeyLift Expandable Interlaminar Stabilization System features an innovative, expandable design that allows for precise, patient-specific surgical intervention. Unlocking the biomechanics of the spine, KeyLift offers three key advantages:

  1. Support – KeyLift provides support at the strongest part of the spinal column, the lamina. This distinguishes it from existing devices that only support the spinous process, which is troublesome in patients with osteoporosis.
  2. Lift – With the capacity to expand up to 4mm in height, KeyLift effectively distracts and relieves nerves, alleviating pain caused by spinal stenosis.
  3. Stabilize – Positioned closer to the spine’s instantaneous axis of rotation, KeyLift promotes disc health by balancing the intervertebral discs.

This groundbreaking technology not only reduces patient discomfort and pain but also significantly shortens recovery times by being performed in an outpatient surgery center, allowing patients to return to their daily lives more quickly.

The KeyLift system’s expandable design is the result of years of research, development, and rigorous testing by the FloSpine team, anchored by Luis Escobar, lead design engineer.

“KeyLift provides a more mechanically stable design in a minimally invasive package,” says Dr. Cheng-Lun Soo, MD, an orthopedic spine surgeon and co-inventor of the KeyLift. “As a spine surgeon of over 25 years, I believe this technology will reach more patients by enabling more interventional physicians to treat mild to moderate spinal stenosis without the fear of a large surgery.”

Like the four other products invented by FloSpine and approved by the FDA, KeyLift has a Florida inspired name. FloSpine is committed to advancing the field of spinal healthcare, and to support its continued growth, it recently expanded its headquarters to a 5,000 square foot facility in the Research Park at Florida Atlantic University, having completed its scale-up at Global Ventures. A majority of FloSpine’s hiring has been from Florida Atlantic University’s College of Engineering, and over the next two years, it plans to increase from 8 employees to 18.

“This is the culmination of years of research and development to deliver a medical device that helps improve the lives of patients suffering from spinal stenosis. Our recent move to larger premises in the Research Park at FAU will allow us to train our surgical and distribution partners to become increasingly competitive in the spinal implant device market,” said Peter Harris, founder and CEO of FloSpine. “This marks two significant achievements for our company as we grow to support our spine devices for both interventional pain physicians and spine surgeons. We are confident that KeyLift will become the standard in treating this condition, offering an overall improved quality of life for patients.”

Andrew Duffell, president of the Research Park at FAU added, “FloSpine’s growth and expansion from Global Ventures into the Research Park is an inspiration to healthtech entrepreneurs and Florida Atlantic students who see their classmates excel in an exciting, growing industry. We very much look forward to supporting the team as it continues to innovate and contribute to the region’s economy.”

In loving memory of Luis Escobar, Senior Design Engineer, and friend.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”